Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin

INTRODUCTION: Warfarin continues to be the most widely used anticoagulant in clinical practice around the world for the prevention of thromboembolic events in patients with atrial fibrillation (AF). The evaluation of the quality of anticoagulation control, estimated by time in therapeutic range (TTR...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silveira, Maria Mariana Barros Melo, Melo, Leiliandry de Araújo, Gomes, Filipe Maia Ferreira, Andrade, Leonardo José de Cupertino Barreto da Rocha, Serur, Isabela Paulino, Piscoya, Isabelle Cecília de Vasconcellos, Gueiros, Raposo Marina, Palmeira do Ó, Kleyton, de Lima, Raul Emídio, Brasileiro, Victor Arthur Eulálio, Vasconcelos, Luydson Richardson Silva, Sobral Filho, Dário Celestino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684853/
https://www.ncbi.nlm.nih.gov/pubmed/31447576
http://dx.doi.org/10.2147/TACG.S197316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684853/
https://www.ncbi.nlm.nih.gov/pubmed/31447576
http://dx.doi.org/10.2147/TACG.S197316

Ejemplares similares